This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Telix Pharmaceuticals has inked a deal to acquire Florida-based radiopharmacy network RLS Radiopharmacies for up to $250 million, the companies announced. RLS Radiopharmacies is the third-largest radiopharmacy network in the U.S. and distributes PET, SPECT, and therapeutic radiopharmaceuticals through 31 radiopharmacies across 18 states, Telix said.
Researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney disease than standard laboratory blood tests.
Vienna, Austria-based Piur Imaging has received clearance from the U.S. Food and Drug Administration (FDA) for its tUS Infinity tomographic 3D ultrasound system. The Piur tUS Infinity is a standalone ultrasound enhancement system capable of upgrading 2D ultrasound devices to capture comprehensive 3D images, the company said. The technology is designed to provide clinicians with detailed volumetric datasets of thyroid lobes and nodules in a single scan.
Advances in automation and artificial intelligence have positively impacted the world of payroll services. Automation can often provide robust services, save time and energy, and allow you to deploy your limited human talent toward more productive areas. However, improvements in automated services do not mean that your business can afford to lose the human touch.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Alpha particles provide precise cancer treatment by delivering high-energy radiation, targeting tumour cells while sparing healthy tissue. The post The Role of Alpha Particles in Radiotheranostics appeared first on Open MedScience.
Osteoarthritis (OA) of the knee affects approximately 365 million individuals and is the leading cause of pain and disability worldwide (1,2). Despite the prevalence and disabling nature of this disease, there is no disease-modifying treatment or cure. Furthermore, commonly used treatments such as intra-articular steroid injection have limited durability and effectiveness and may be associated with cartilage injury and OA progression (3–6).
Osteoarthritis (OA) of the knee affects approximately 365 million individuals and is the leading cause of pain and disability worldwide (1,2). Despite the prevalence and disabling nature of this disease, there is no disease-modifying treatment or cure. Furthermore, commonly used treatments such as intra-articular steroid injection have limited durability and effectiveness and may be associated with cartilage injury and OA progression (3–6).
Publication date: Available online 21 September 2024 Source: Clinical Radiology Author(s): Daniel Togher, Geraldine Dean, Jo Moon, Richard Mayola, Arman Medina, Jadwiga Repec, Moesha Meheux, Sarah Mather, Mathew Storey, Simon Rickaby, Mohamed Ziad Abubacker, Susan Cheng Shelmerdine
To report the 24-month outcomes and subgroup analysis evaluating the safety and effectiveness of the genicular artery embolization (GAE) for the treatment of symptomatic knee osteoarthritis (OA).
Publication date: Available online 21 September 2024 Source: Clinical Radiology Author(s): Kelly K. Horst, Zhongxing Zhou, Nate C. Hull, Paul G. Thacker, Blake A. Kassmeyer, Matthew P. Johnson, Nadir Demirel, Andy D.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content